Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma (Hodgkin's and Non-Hodgkin's)”

1,379 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,379 results

Not applicableStudy completedNCT01904175
What this trial is testing

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

Who this might be right for
Hodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more
Duke University 48
Testing effectiveness (Phase 2)Ended earlyNCT01699581
What this trial is testing

Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant

Who this might be right for
Hodgkin's LymphomaMultiple MyelomaNon-Hodgkin's Lymphoma
Greg Monohan 35
Early research (Phase 1)Study completedNCT03498430
What this trial is testing

Copanlisib Chinese PK Study

Who this might be right for
Lymphoma, Non-Hodgkin
Bayer 13
Large-scale testing (Phase 3)Study completedNCT00329030
What this trial is testing

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Who this might be right for
Lymphoma, B-CellLymphoma, Large-Cell, ImmunoblasticLymphoma, Non-Hodgkin
National Heart, Lung, and Blood Institute (NHLBI) 224
Testing effectiveness (Phase 2)Study completedNCT02723071
What this trial is testing

Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 48
Testing effectiveness (Phase 2)Study completedNCT01663714
What this trial is testing

Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 30
Early research (Phase 1)Active Not RecruitingNCT04447716
What this trial is testing

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin Lymphoma+5 more
Thomas Jefferson University 4
Not applicableStudy completedNCT02434484
What this trial is testing

Symbenda Post-Marketing Surveillance (PMS)

Who this might be right for
Lymphoma, Non-HodgkinLymphocytic LeukemiaMultiple Myeloma
Eisai Korea Inc. 84
Testing effectiveness (Phase 2)WithdrawnNCT00881387
What this trial is testing

Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment

Who this might be right for
Lymphoma
University of Miami
Early research (Phase 1)UnknownNCT00008021
What this trial is testing

Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00021372
What this trial is testing

Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fox Chase Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01153971
What this trial is testing

Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 47
Not applicableLooking for participantsNCT05921812
What this trial is testing

Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Sohag University 70
Testing effectiveness (Phase 2)Ended earlyNCT00265928
What this trial is testing

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Virginia 46
Not applicableStudy completedNCT06171945
What this trial is testing

Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerPhysical ActivityCancer Survivorship+2 more
UNC Lineberger Comprehensive Cancer Center 63
Testing effectiveness (Phase 2)UnknownNCT02456207
What this trial is testing

A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Non Hodgkin's Lymphoma
Sinocelltech Ltd. 80
Early research (Phase 1)UnknownNCT04796675
What this trial is testing

Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin's Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Testing effectiveness (Phase 2)Study completedNCT00636909
What this trial is testing

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCML Chronic Phase, Accelerated Phase, or Blast Crisis+6 more
Beth Israel Deaconess Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT00109967
What this trial is testing

CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 71
Not applicableNo Longer AvailableNCT02715843
What this trial is testing

Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma

Who this might be right for
Non-Hodgkin's B-cell Lymphoma
Molecular Templates, Inc.
Load More Results